Drug Type CRISPR/Cas9 |
Synonyms- |
Target |
Action modulators |
Mechanism β-glucuronidase modulators(glucuronidase beta modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Mucopolysaccharidosis VII | Preclinical | China | 02 Jul 2025 | |
Mucopolysaccharidosis VII | Preclinical | China | 02 Jul 2025 |